“…21 In addition, they have been capable of detecting circulating MUC1 in sandwich enzyme-linked immunosorbent assays, improving current detection limits, 19 and have been extensively studied as radiopharmaceuticals for their potential in gamma-camera and single-photon emission computed tomography (SPECT) imaging. [21][22][23] Furthermore, they have been shown to be particularly promising agents in photodynamic therapy as phototoxic agents 24 and delivery agents of standard chemotherapy such as doxorubicin. 25 Finally, the MUC1 aptamers have been successfully used in nanoparticle (NP) formulation, described both from our own group 26 for silica NPs and from a different group for liposomal formulation in conjunction with paclitaxel.…”